Ami Fadia
Stock Analyst at Needham
(3.86)
# 682
Out of 4,980 analysts
384
Total ratings
49.14%
Success rate
9.87%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Reiterates: Hold | n/a | $142.61 | - | 42 | Sep 4, 2025 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $202 | $126.90 | +59.18% | 34 | Aug 28, 2025 | |
| IMRX Immuneering | Reiterates: Buy | $8 | $8.14 | -1.72% | 18 | Aug 26, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $57 → $56 | $40.45 | +38.44% | 25 | Aug 7, 2025 | |
| MRUS Merus | Maintains: Buy | $97 → $96 | $67.13 | +43.01% | 30 | Aug 6, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $18 → $16 | $7.25 | +120.69% | 21 | Aug 6, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $150 | $124.12 | +20.85% | 16 | Aug 4, 2025 | |
| ALKS Alkermes | Reiterates: Buy | $45 | $26.93 | +67.10% | 3 | Jul 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $30 | $23.80 | +26.05% | 10 | Jun 26, 2025 | |
| COGT Cogent Biosciences | Reiterates: Hold | n/a | $12.75 | - | 23 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $40.21 | +98.96% | 12 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.71 | +54.12% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.63 | +206.75% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $15.81 | +20.18% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $33.19 | +47.63% | 37 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $139 | $141.25 | -1.59% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $6.99 | +314.88% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $15.08 | +2,022.02% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $26.62 | +181.74% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.69 | +3,140.67% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $22.12 | +184.81% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $5.62 | -10.95% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $19.57 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.27 | +1,632.28% | 4 | Jan 3, 2018 |
Biogen
Sep 4, 2025
Reiterates: Hold
Price Target: n/a
Current: $142.61
Upside: -
Jazz Pharmaceuticals
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $126.90
Upside: +59.18%
Immuneering
Aug 26, 2025
Reiterates: Buy
Price Target: $8
Current: $8.14
Upside: -1.72%
Revolution Medicines
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $56
Current: $40.45
Upside: +38.44%
Merus
Aug 6, 2025
Maintains: Buy
Price Target: $97 → $96
Current: $67.13
Upside: +43.01%
Day One Biopharmaceuticals
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $16
Current: $7.25
Upside: +120.69%
Axsome Therapeutics
Aug 4, 2025
Reiterates: Buy
Price Target: $150
Current: $124.12
Upside: +20.85%
Alkermes
Jul 29, 2025
Reiterates: Buy
Price Target: $45
Current: $26.93
Upside: +67.10%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $30
Current: $23.80
Upside: +26.05%
Cogent Biosciences
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $12.75
Upside: -
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $40.21
Upside: +98.96%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $22.71
Upside: +54.12%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $1.63
Upside: +206.75%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $15.81
Upside: +20.18%
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $33.19
Upside: +47.63%
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $141.25
Upside: -1.59%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $6.99
Upside: +314.88%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $15.08
Upside: +2,022.02%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $26.62
Upside: +181.74%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.69
Upside: +3,140.67%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $22.12
Upside: +184.81%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $5.62
Upside: -10.95%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $19.57
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.27
Upside: +1,632.28%